Question 1

What’s the financial overview for Ventyx Biosciences, Inc.?

Accepted Answer

Ventyx Biosciences, Inc.’s market cap stands at $0.00 trillion right now. The company’s trailing twelve-month earnings per share EPS is $-1.74, with a dividend yield of N/A%. Their next earnings report is set for January 29, 2025, and the estimated EPS for that period is $1.61. You can also check out summaries of their income statement, balance sheet, and cash flow details for a fuller picture of their financials.

Question 2

How can I analyze historical data?

Accepted Answer

To analyze historical data with AI tools, apply the date range filter above the table to focus on a specific period. The table displays daily open, high, low, close prices, and volume, enabling you to spot trends and patterns. Use these insights to make informed decisions based on historical performance.

Question 3

What does Ventyx Biosciences, Inc. Stock ROE tell us?

Accepted Answer

Ventyx Biosciences, Inc. stock ROE shows positive market sentiment. A higher ROE means the company’s management is doing a better job at using equity financing to drive income and growth. It’s a handy metric for comparing how a company stacks up against its competitors or the broader market.

Question 4

What do Analysts say about Ventyx Biosciences, Inc.?

Accepted Answer

0 number of Analysts recommended buying Ventyx Biosciences, Inc. the stock and 0 analysts recommended selling the stock.

Metric	Q4 2024	Q3 2024	Q2 2024	Q1 2024
Revenue	$0.00	$0.00	$0.00	$0.00
Cost of Revenue	$0.00	$0.00	$316000.00	$408000.00
Gross Profit	$0.00	$0.00	-$316000.00	-$408000.00
Gross Profit Ratio	$0.00
R&D Expenses	$24.82M	$30.63M	$27.80M	$33.75M
SG&A Expenses	$7.60M	$7.92M	$7.59M	$7.61M
Operating Expenses	$32.42M	$38.55M	$35.40M	$41.36M
Total Costs & Expenses	$32.42M	$38.55M	$35.71M	$41.77M
Interest Income	$3.06M	$3.35M	$3.78M	$3.23M
Interest Expense	$0.00	$0.00	$0.00	$0.00
Depreciation & Amortization	$315000.00	$309000.00	$316000.00	$408000.00
EBITDA	-$32.10M	-$38.24M	-$35.40M	-$41.36M
EBITDA Ratio
Operating Income	-$32.42M	-$38.55M	-$35.71M	-$41.77M
Operating Income Ratio
Other Income/Expenses (Net)	$3.07M	$3.30M	$3.76M	$3.20M
Income Before Tax	-$29.35M	-$35.25M	-$31.95M	-$38.57M
Income Before Tax Ratio
Income Tax Expense	$0.00	$0.00	$0.00	$364724.00
Net Income	-$29.35M	-$35.25M	-$31.95M	-$38.57M
Net Income Ratio
EPS	-$0.43	-$0.50	-$0.45	-$0.62
Diluted EPS	-$0.43	-$0.50	-$0.45	-$0.62
Weighted Avg Shares Outstanding	$70.81M	$70.67M	$70.55M	$61.83M
Weighted Avg Shares Outstanding (Diluted)	$70.81M	$70.67M	$70.55M	$61.83M

Ventyx Biosciences, Inc.